Stay updated on Cusatuzumab Combo in AML: Clinical Trial
Sign up to get notified when there's something new on the Cusatuzumab Combo in AML: Clinical Trial page.

Latest updates to the Cusatuzumab Combo in AML: Clinical Trial page
- Check5 days agoChange DetectedAdded a new revision entry (v3.4.3) to the history and removed the prior v3.4.2 entry.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAddition: Revision: v3.4.2; Deletions: Notice about government funding lapse and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about government funding and operational status; updated the site revision to v3.4.1, and removed v3.4.0. No changes to core study data or content were detected; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe UI now includes a 'Show glossary' option and explicit color-coding (green for additions, red for deletions). The revision note is updated to v3.4.0 and the 'No FEAR Act data' label text is adjusted from the previous version.SummaryDifference0.6%

- Check62 days agoChange DetectedRevision v3.3.4 was added to the history and the previous v3.3.3 entry was removed.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.3.3 is added and the HHS Vulnerability Disclosure link is removed. Revision: v3.3.2 is removed.SummaryDifference0.1%

Stay in the know with updates to Cusatuzumab Combo in AML: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cusatuzumab Combo in AML: Clinical Trial page.